NTR.TO · TOR · Basic Materials
Nutrien Ltd.
Also onConsensus Drift
Implied value per share
CAD 43.57
Market price
CAD 107.95
Implied upside
-59.6%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · USD model at 1.3982
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 24.0bn | USD 21.4bn | USD 19.1bn | USD 17.0bn | USD 15.2bn | -10.8% |
| EBIT | USD 4.0bn | USD 3.5bn | USD 3.1bn | USD 2.8bn | USD 2.5bn | -10.8% |
| NOPAT | USD 2.9bn | USD 2.6bn | USD 2.3bn | USD 2.1bn | USD 1.8bn | -10.8% |
| Add depreciation & amortisation | USD 1.8bn | USD 1.6bn | USD 1.5bn | USD 1.3bn | USD 1.2bn | -10.8% |
| Less capital expenditure | USD -1.9bn | USD -1.7bn | USD -1.5bn | USD -1.3bn | USD -1.2bn | -10.8% |
| Less increase in working capital | USD 166.8m | USD 148.8m | USD 132.7m | USD 118.4m | USD 105.6m | +10.8% |
| Free cashflow to firm | USD 3.0bn | USD 2.7bn | USD 2.4bn | USD 2.2bn | USD 1.9bn | -10.8% |
| Discount factor | 0.9615 | 0.8888 | 0.8216 | 0.7595 | 0.7020 | - |
| Present value | USD 2.9bn | USD 2.4bn | USD 2.0bn | USD 1.6bn | USD 1.3bn | -17.5% |
| Present Value Of The Forecast | USD 10.3bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 3.30% | CAD assumption - no free live source available for this market (assumption) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 1.051 | Reported 1.076, pulled toward 1.0 (Blume) |
| Cost of equity | 9.08% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.87% | Interest expense / average total debt |
| Market capitalisation | USD 51.5bn | 81.1% of capital |
| Total debt | USD 12.0bn | 18.9% of capital, book value as a proxy |
| Tax rate | 26.5% | Effective, capped at statutory |
| WACC | 8.18% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
61% of EV
- Forecast FCFF, final year
- USD 1.9bn
- Capex at depreciation, working capital in reinvestment
- USD 1.8bn
- Less reinvestment at g/ROIC (30.6% of NOPAT)
- USD -562.3m
- Capitalised
- USD 1.3bn
- ROIC (WACC floor)
- 8.2%
- Terminal value, undiscounted
- USD 23.1bn
- Terminal value, discounted
- USD 16.2bn
- Enterprise value
- USD 26.5bn
- Less net debt
- USD 11.3bn
- Equity value
- USD 15.2bn
Exit at 10.1x EBITDA
72% of EV
- Terminal value, undiscounted
- USD 36.9bn
- Terminal value, discounted
- USD 25.9bn
- Enterprise value
- USD 36.2bn
- Less net debt
- USD 11.3bn
- Equity value
- USD 24.9bn
Spread between methods: 49%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 6.18% | 49.40 | 51.25 | 53.54 | 56.51 | 60.51 |
| 7.18% | 38.32 | 38.92 | 39.62 | 40.43 | 41.42 |
| 8.18% | 30.83 | 31.00 | 31.16 | 31.32 | 31.48 |
| 9.18% | 25.65 | 25.79 | 25.93 | 26.06 | 26.20 |
| 10.18% | 21.47 | 21.59 | 21.71 | 21.83 | 21.95 |
Outlined: this model. Green text: above today's price of 77.21. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | -10.8% | 3.7% | +14.5pp |
| EBIT margin | 16.5% | 30.7% | +14.2pp |
| Discount rate | 8.2% | 5.2% | -3.0pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.